Neurology has seen a surge in drug options, necessitating comparative effectiveness research to guide treatment decisions and address disparities in access and outcomes. Collaborative efforts between ...

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...

Neurofilament light chains in the serum and cerebrospinal fluid show strong potential for monitoring neurodegenerative and ...

Please provide your email address to receive an email when new articles are posted on . Treatment with tolebrutinib 60 mg for 12 weeks reduced new gadolinium-enhancing and new or enlarging T2 lesions ...

Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Focal treatment-resistant epilepsy ...

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...

This describes Retraining and Control Therapy, or ReACT, the reason for being of UAB’s latest startup, ReACT FND Health. The company’s chief scientific officer and founder is clinical psychologist ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...

Demi Morris is celebrating getting her first nursing role, a career she chose after receiving specialist neurology care while ...